ACTION: On February 24, 2009, Rainforest Acquisition Inc., a wholly-owned subsidiary of Abbott Laboratories, completed its tender offer for Advanced Medical Optics, Inc. (“EYE”) Common Shares. The merger was subsequently consummated on February 26, 2009. As a result, each EYE Common Share will be converted into the right to receive $22.00 net cash per share.
This action will be coordinated with the Options Clearing Corporation.
CATEGORY: Cash Settlement
EQUITY SYMBOL: Advanced Medical Optics, Inc. (“EYE”)
ONE CHICAGO SYMBOL: EYE1C will be de-listed
CME FUTURES SYMBOL: EYE will be de-listed
MULTIPLIER: 100 (e.g., 1.00 equals $100.00)
EFFECTIVE DATE: Monday, March 2, 2009
NEW DELIVERABLE PER CONTRACT: $2,200.00 ($22.00 x 100)
APPLICABLE CONTRACT MONTHS: March, April, June, and September 2009
SETTLEMENT PRICES AND POSITIONS: The maturity date for all EYE1C Security Futures will be accelerated to March 2, 2009.
NOTES: The forecasted effect of the upcoming corporate event on each clearing firms’ positions can be viewed in infopac in the Corporate Event Initial Forecast Report (ONE712), the Corporate Event Final Forecast Report (ONE713), and the Corporate Event Forecast Audit Report (CPDBU710).
If you have any questions regarding the information provided in the document, please call CME Clearing risk management hotline at (312) 648-3888.